Preview Mode Links will not work in preview mode

Dec 18, 2018

Mass spectrometry (MS) has long been a valuable tool for drug discovery, and steady advances in its capabilities and performance have generated powerful insights for the pharmaceutical industry. The latest MS innovations are now helping biotherapeutics developers overcome challenges around sample preparation and...


Dec 11, 2018

Magnetic Resonance Imaging (MRI) can be used to provide quantitative measurements in the form of imaging biomarkers. These measurements have a number of attractive characteristics: They are non-invasive, can provide organ and lesion localisation of morphology, physiology and metabolism and can be repeated...


Dec 4, 2018

If we have learned anything from scientific research in the last 20 years, it is that finding cures to complex diseases is difficult. Despite the promise of the genomic revolution, disease progression and patient outcomes are still not easily predicted by genetic factors alone.

Part of the explanation for this gap is...


Nov 27, 2018

Regulatory approval of CAR-T cell therapies in 2017 placed the spotlight on immunotherapy approaches that use live cells to attack tumours – a major shift in oncology treatment.

Yet even this groundbreaking therapy has limitations, such as when patients already immuno-depressed from a first-line treatment do not have...


Nov 20, 2018

The staggering clinical trial failure rate of experimental drugs indicates that despite huge investments in novel technologies over the years, productivity gains in the pharmaceutical industry remained elusive. It is therefore generally agreed that the current biopharma model is unsustainable and disruptive approaches...